ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Service: Economic Modeling

In The News Targeted Therapies for Metastatic Colorectal Cancer: A Systematic Review of Cost Effectiveness
In The News Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand
In The News Bayesian Calibration of a Cervical Cancer Model Using Markov Chain Monte Carlo
In The News Cost Effectiveness of Donepezil 23 mg in the Treatment of Moderate to Severe Alzheimer’s Disease from a US Payor Perspective
In The News Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer
In The News Budget Impact Analysis of Increasing LMWH/FXI Utilization
In The News Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States
In The News Cost effectiveness of atazanavir-ritonavir vs. lopinavir-ritonavir in HIV-infected patients initiating first-line antiretroviral therapy
In The News Cost-effectiveness of human papillomavirus vaccination and screening in Spain

Posts pagination

< Previous page 1 … 9 10 11 12 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health